Generate a tailored SOP for Dr. Benjamin Kleinstiver. Improve your application with a focused, well-structured draft.
Benjamin P. Kleinstiver is an Associate Professor at Harvard Medical School, specializing in genome engineering technologies for medical applications. His research focuses on developing novel genome editing tools that can overcome the limitations of traditional CRISPR enzymes. The Kleinstiver lab aims to create versatile and effective technologies for precise genome modifications that can address a variety of human diseases, including inborn errors of immunity, spinal muscular atrophy, and sickle cell disease. The lab's innovations have significantly improved the safety and efficiency of genome editing by engineering enzymes with enhanced properties. Kleinstiver's research emphasizes collaborative efforts with clinicians and researchers to solve significant biological challenges and foster an environment where trainees can learn and thrive in their academic careers. For more information about his recent publications, please visit the lab's publication page.
Harvard Medical School • Boston, MA
Leading research in genome engineering and collaborating with clinical researchers.
Administered by the Division of Medical Sciences (DMS). GRE is not required and will not be considered for BBS, Immunology, and Neuroscience.